Results 251 to 260 of about 62,474 (297)
Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report. [PDF]
BMC OphthalmolHashiya N +5 more
europepmc +1 more source
Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study. [PDF]
BMJ Open OphthalmolHusum YS +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neovascular Age-Related Macular Degeneration
Ophthalmologica, 2012<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele +2 more
openaire +5 more sources
Ranibizumab for Neovascular Age-Related Macular Degeneration [PDF]
New England Journal of Medicine, 2006 Ranibizumab--a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A--has been evaluated for the treatment of neovascular age-related macular degeneration.In this multicenter, 2-year, double-blind, sham-controlled study, we randomly assigned patients with age-related macular ...
Peter K. Kaiser +6 more
openaire +2 more sources
Macular translocation for neovascular age-related macular degeneration
Cochrane Database of Systematic Reviews, 2008Macular translocation has been proposed by vitreoretinal surgeons to displace the neuroretinal tissue onto healthy retinal pigment epithelium and choroid when the macula has been invaded by subretinal neovascularisation.This review aims at assessing the effectiveness of macular translocation for preserving or improving vision in patients with ...
Eandi CM +2 more
openaire +4 more sources
Imaging in Neovascular Age-Related Macular Degeneration
Seminars in Ophthalmology, 2011Imaging plays an essential role in the diagnosis and treatment of age-related macular degeneration (AMD). This review describes the imaging modalities most commonly employed by ophthalmologists caring for patients with neovascular AMD. Imaging modalities discussed include fluorescein angiography, optical coherence tomography, indocyanine green ...
Anne E. Fung +2 more
openaire +3 more sources
Guidance for the treatment of neovascular age-related macular degeneration [PDF]
Acta Ophthalmologica Scandinavica, 2007 Neovascular age-related macular degeneration is becoming an increasing socio-medical problem as the proportion of the aged population is continuously increasing. However, new insights in the pathogenesis of the disease offer the opportunity to develop targeted therapies that attack the disease process more successfully than ever.
Schmidt Erfurth UM +9 more
openaire +2 more sources
Neovascular Age-Related Macular Degeneration
2015Age-related macular degeneration (AMD) is the leading cause of severe vision loss in individuals over the age of 50 years. Choroidal neovascularization (CNV) is the hallmark of 'wet' or 'exudative' AMD, and is responsible for approximately 90% of cases of severe vision loss due to AMD. Vascular endothelial growth factor (VEGF) is a key component in the
Andrew P Schachat +2 more
openaire +2 more sources
Age-related Macular Degeneration and Choroidal Neovascularization
American Journal of Ophthalmology, 1993The neovascular variant of age-related macular degeneration is amenable to laser photocoagulation treatment within well-defined guidelines established by clinical trials. However, only a limited number of patients meet eligibility criteria for this form of treatment, principally because of the ill-defined, or occult nature, of the choroidal ...
K. Bailey Freund +2 more
openaire +3 more sources